Thomas P Mc Donnell Net Worth

The estimated Net Worth of Thomas P Mc Donnell is at least $3.45 Thousand dollars as of 19 May 2016. Thomas Donnell owns over 3,000 units of Neos Therapeutics Inc stock worth over $3,450 and over the last 9 years Thomas sold NEOS stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Thomas Donnell NEOS stock SEC Form 4 insiders trading

Thomas has made over 1 trades of the Neos Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Thomas bought 3,000 units of NEOS stock worth $22,680 on 19 May 2016.

The largest trade Thomas's ever made was buying 3,000 units of Neos Therapeutics Inc stock on 19 May 2016 worth over $22,680. On average, Thomas trades about 429 units every 0 days since 2015. As of 19 May 2016 Thomas still owns at least 3,000 units of Neos Therapeutics Inc stock.

You can see the complete history of Thomas Donnell stock trades at the bottom of the page.

What's Thomas Donnell's mailing address?

Thomas's mailing address filed with the SEC is 2940 N State Hwy 360 Service Rd E #400, Grand Prairie, TX 75050, USA.

Insiders trading at Neos Therapeutics Inc

Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P...., and Bryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.

What does Neos Therapeutics Inc do?

Complete history of Thomas Donnell stock trades at Neos Therapeutics Inc

Neos Therapeutics Inc executives and stock owners

Neos Therapeutics Inc executives and other stock owners filed with the SEC include:

• Gerald McLaughlin,
  President, Chief Executive Officer, Director
• Richard Eisenstadt,
  Chief Financial Officer, Treasurer
• John Limongelli,
  Senior Vice President, General Counsel and Corporate Secretary
• Alan Heller,
  Independent Chairman of the Board
• Linda Szyper,
  Independent Director
• John Schmid,
  Independent Director
• Gregory Robitaille,
  Independent Director
• Bryant Fong,
  Independent Director
• James Robinson,
  Independent Director
• Beth Hecht,
  Independent Director
• Vipin K Garg,
  President, CEO & Director
• Juergen Martens,
  Chief Tech/Operations Officer
• Thomas P Mc Donnell,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Partners 2007, L.P.Presidio...,
  
• Dorothy Engelking,
  VP of Regulatory Affairs
• Mark Tengler,
  Chief Technology Officer
• Ralph Essex Capital Corp Ia...,
  
• Andrew G Delaware Street Ca...,
  
• Jack W Schuler,
  10% owner
• Venture Assoicates Ii Llcbu...,
  
• James E Deerfield Mgmt L.P....,